Sarah Fortune

Biography

Dr. Sarah Fortune is affiliated to Department of infectious diseases, university of harvard. Dr. Sarah Fortune is currently providing services as professor. Dr. Sarah Fortune has authored I145and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. 1 contributions have acclaimed recognition from honourable subject experts around the world. Dr. Sarah Fortune is actively associated with different societies and academies. Dr. Sarah Fortune academic career is decorated with several reputed awards and funding. Dr. Sarah Fortune research interests include One of the striking features about tuberculosis infection is the wide range of clinical outcomes. Many infected individuals will remain clinically well but some will become sick and die of their infection. Similarly, most people treated with the appropriate drug regimen will be successfully cured and yet some will develop recurrent disease. The biologic challenge in developing better interventions for tuberculosis requires us to improve on partial success.. Dr. Sarah Fortune is affiliated to Department of infectious diseases, university of harvard. Dr. Sarah Fortune is currently providing services as professor. Dr. Sarah Fortune has authored I145and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. 1 contributions have acclaimed recognition from honourable subject experts around the world. Dr. Sarah Fortune is actively associated with different societies and academies. Dr. Sarah Fortune academic career is decorated with several reputed awards and funding. Dr. Sarah Fortune research interests include One of the striking features about tuberculosis infection is the wide range of clinical outcomes. Many infected individuals will remain clinically well but some will become sick and die of their infection. Similarly, most people treated with the appropriate drug regimen will be successfully cured and yet some will develop recurrent disease. The biologic challenge in developing better interventions for tuberculosis requires us to improve on partial success..

Research Interest

One of the striking features about tuberculosis infection is the wide range of clinical outcomes. Many infected individuals will remain clinically well but some will become sick and die of their infection. Similarly, most people treated with the appropriate drug regimen will be successfully cured and yet some will develop recurrent disease. The biologic challenge in developing better interventions for tuberculosis requires us to improve on partial success.